Maintenance treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis

被引：22

作者：

Hoiby, N ^{[1
]}

Koch, C

机构：

[1] Univ Copenhagen, Rigshosp, Dept Clin Microbiol 9301, DK-2100 Copenhagen O, Denmark

[2] Univ Copenhagen, Rigshosp, Danish Cyst Fibrosis Ctr 5003, DK-2100 Copenhagen, Denmark

来源：

THORAX | 2000年 / 55卷 / 05期

关键词：

D O I：

10.1136/thorax.55.5.349

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：349 / 350

页数：2

共 25 条

[1]

[Anonymous], 1977, ACTA PATHOL MIC SC

[2] Controlled trial of inhaled budesonide in patients with cystic fibrosis and chronic bronchopulmonary Pseudomonas aeruginosa infection [J].

Bisgaard, H ;

Pedersen, SS ;

Nielsen, KG ;

Skov, M ;

Laursen, EM ;

Kronborg, G ;

Reimert, CM ;

Hoiby, N ;

Koch, C .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (04) :1190-1196

[3] DEVELOPMENT OF ANTIBIOTIC-RESISTANCE IN PSEUDOMONAS-AERUGINOSA DURING 2 DECADES OF ANTIPSEUDOMONAL TREATMENT AT THE DANISH-CF-CENTER [J].

CIOFU, O ;

GIWERCMAN, B ;

PEDERSEN, SS ;

HOIBY, N .

APMIS, 1994, 102 (09) :674-680

[4] Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs [J].

Elborn, JS ;

Prescott, RJ ;

Stack, BHR ;

Goodchild, MC ;

Bates, J ;

Pantin, C ;

Ali, N ;

Shale, DJ ;

Crane, M .

THORAX, 2000, 55 (05) :355-358

[5]

Frederiksen B, 1996, PEDIATR PULM, V21, P153, DOI 10.1002/(SICI)1099-0496(199603)21:3<153::AID-PPUL1>3.0.CO

[6]

2-R

[7]

GOLDSTEIN W, 1986, AM REV RESPIR DIS, V134, P49

[8] Host defence (cationic) peptides - What is their future clinical potential? [J].

Hancock, REW .

DRUGS, 1999, 57 (04) :469-473

[9] COLISTIN INHALATION-THERAPY IN CYSTIC-FIBROSIS PATIENTS WITH CHRONIC PSEUDOMONAS-AERUGINOSA LUNG INFECTION [J].

JENSEN, T ;

PEDERSEN, SS ;

GARNE, S ;

HEILMANN, C ;

HOIBY, N ;

KOCH, C .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 19 (06) :831-838

[10]

KOBAYASHI H, 1995, J INFECT CHEMOTHER, V1, P1, DOI DOI 10.1007/BF02347725

← 1 2 3 →